Murata T - Search Results

1

Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial.

Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, Kotobuki Y, Linden S, Reifsnider OS, Rakonczai P, Stargardter M, Murata T, Hirase T, Nitta D. Tsutsui H, et al. Among authors: murata t. J Cardiol. 2023 Jun;81(6):522-530. doi: 10.1016/j.jjcc.2023.02.007. Epub 2023 Feb 28. J Cardiol. 2023. PMID: 36858174 Free article.

2

Treatment strategy modification and its implication on the medical cost of fractional flow reserve-guided percutaneous coronary intervention in Japan.

Tanaka N, Kohsaka S, Murata T, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, Nakamura M. Tanaka N, et al. Among authors: murata t. J Cardiol. 2019 Jan;73(1):38-44. doi: 10.1016/j.jjcc.2018.05.018. Epub 2018 Jul 2. J Cardiol. 2019. PMID: 30041908 Free article.

3

[A Cost-effectiveness Analysis of Sunitinib vs. Interferon-alpha in Patient with Advanced Renal Cell Carcinoma in Japan].

Tomura K, Naito Y, Sunaga T, Kurihara T, Usuda M, Nagatani A, Ogawa Y, Akiyama N, Sasaki H, Murata T, Sakamaki H, Kogo M, Sasaki T. Tomura K, et al. Among authors: murata t. Yakugaku Zasshi. 2018;138(11):1397-1407. doi: 10.1248/yakushi.17-00189. Yakugaku Zasshi. 2018. PMID: 30381648 Free article. Japanese.

4

Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial.

Kaku K, Haneda M, Sakamaki H, Yasui A, Murata T, Ustyugova A, Chin R, Hirase T, Shibahara T, Hayashi N, Kansal A, Kaspers S, Okamura T. Kaku K, et al. Among authors: murata t. Clin Ther. 2019 Oct;41(10):2021-2040.e11. doi: 10.1016/j.clinthera.2019.07.016. Epub 2019 Sep 25. Clin Ther. 2019. PMID: 31561882 Free article. Clinical Trial.

5

Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA^® Trial.

Watada H, Sakamaki H, Yabe D, Yamamoto F, Murata T, Hanada K, Hirase T, Okamura T. Watada H, et al. Among authors: murata t. Diabetes Ther. 2020 Aug;11(8):1721-1734. doi: 10.1007/s13300-020-00852-8. Epub 2020 Jun 17. Diabetes Ther. 2020. PMID: 32557283 Free PMC article.

6

Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan.

Mizuoka T, Sakamaki H, Fuji S, Saito S, Murata T, Ohno S, Inubashiri N, Oshima T, Yamamoto K. Mizuoka T, et al. Among authors: murata t. J Med Econ. 2023 Jan-Dec;26(1):1122-1133. doi: 10.1080/13696998.2023.2254162. J Med Econ. 2023. PMID: 37656225 Free article.

7

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M. Igarashi A, et al. Among authors: murata t. Clinicoecon Outcomes Res. 2015 Oct 7;7:505-20. doi: 10.2147/CEOR.S89833. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 26504403 Free PMC article.

8

Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan.

Kamae I, Hashimoto Y, Koretsune Y, Tanahashi N, Murata T, Phatak H, Liu LZ, Tang AC, Feng Wang P, Okumura K. Kamae I, et al. Among authors: murata t. Clin Ther. 2015 Dec 1;37(12):2837-51. doi: 10.1016/j.clinthera.2015.10.007. Epub 2015 Nov 19. Clin Ther. 2015. PMID: 26608819 Free article.

9

Cost-Effectiveness Analysis of Long-Term Intermittent Self-Catheterization with Hydrophilic-Coated and Uncoated Catheters in Patients with Spinal Cord Injury in Japan.

Watanabe T, Yamamoto S, Gotoh M, Saitoh T, Yokoyama O, Murata T, Takeda M. Watanabe T, et al. Among authors: murata t. Low Urin Tract Symptoms. 2017 Sep;9(3):142-150. doi: 10.1111/luts.12122. Epub 2015 Nov 30. Low Urin Tract Symptoms. 2017. PMID: 28868661

10

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan.

Akazawa M, Igarashi A, Ebata N, Murata T, Zeniya S, Haga Y, Nozawa K, Fujii K, Taguchi T. Akazawa M, et al. Among authors: murata t. J Pain Res. 2019 Sep 23;12:2785-2797. doi: 10.2147/JPR.S203712. eCollection 2019. J Pain Res. 2019. PMID: 31576163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,770 results

Search Page